FLEMINGTON, N.J.--(BUSINESS WIRE)--NovaDel Pharma Inc. (AMEX: NVD), a specialty pharmaceutical company developing oral spray formulations for a broad range of marketed treatments, today announced that Mr. Steven B. Ratoff, NovaDel’s Chairman, interim President and Chief Executive Officer, is scheduled to provide an update on the Company at the BIO Investor Forum 2007.
